| Prophylaxie et traitement par isavuconazole chez les receveurs de cellules souches hématopoïétiques allogéniques | |  | | 2025 | 56 | 328 |
|
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | | | 2025 | 16 | 113 |
|
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | | | 2024 | 91 | 251 |
|
| Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers | PLOS ONE | | | 2021 | 380 | 506 |
|
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection | | | 2021 | 284 | 603 |
|
| Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2 | PLOS ONE | | | 2021 | 331 | 221 |
|
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | | | 2021 | 251 | 361 |
|
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | | | 2021 | 258 | 473 |
|
| Guillain-Barré syndrome as a complication of SARS-CoV-2 infection | Brain, behavior, and immunity | | | 2020 | 276 | 203 |
|
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | | | 2020 | 471 | 167 |
|
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation |  | | 2020 | 355 | 1 |
|
| Quelle place pour les stéroïdes dans le traitement des maladies infectieuses ? | Revue médicale suisse | | | 2013 | 696 | 644 |
|
